نتایج جستجو برای: anti hiv drug

تعداد نتایج: 1070289  

Journal: :Antiviral therapy 2009
Laura Milazzo Ilaria Caramma Alessia Lai Michela Violin Chiara De Maddalena Miriam Cesari Massimo Galli Claudia Balotta

BACKGROUND Telbivudine is a potent inhibitor of hepatitis B virus (HBV) replication without anti-HIV type-1 (HIV-1) activity demonstrated in vitro; however, very few clinical data on HIV-1-infected patients are available at present. Because it represents a therapeutic option in HIV-1-HBV-coinfected patients who do not require antiretroviral therapy, we strictly monitored three HIV-1-HBV-coinfec...

2018

Background Tuberculous meningitis (TBM) is the most severe form of tuberculosis. Co-infection with HIV increases the risk of developing TBM, complicates treatment, and substantially worsens outcome. Whether corticosteroids confer a survival benefit in HIV-infected patients with TBM remains uncertain. Hepatitis is the most common drug-induced serious adverse event associated with anti-tuberculos...

Journal: :Transactions of The Royal Society of Tropical Medicine and Hygiene 2021

Abstract Background In Nigeria, indiscriminate use of antimalarial drugs may contribute to the threat drug resistance, but this has not been evaluated among people living with human immunodeficiency virus (HIV). Methods HIV-positive adults attending a university hospital HIV clinic and HIV-negative adult volunteers from community positive blood film were treated artemether–lumefantrine. Parasit...

Journal: :Blood 2009
Wei Zhang Michael A Nardi William Borkowsky Zongdong Li Simon Karpatkin

Patients with HIV-1 immune-related thrombocytopenia (HIV-1-ITP) have a unique Ab against platelet GPIIIa49-66 capable of inducing oxidative platelet fragmentation in the absence of complement. HIV-1-seropositive drug abusers are more prone to develop immune thrombocytopenia than non-drug abusers and have a higher coinfection with hepatitis C virus (HCV) than non-drug abusers (90% vs 30%). Molec...

2017

Pre-exposure prophylaxis (PrEP) is an HIV prevention strategy that involves HIV-negative people taking anti-HIV drugs to reduce their risk of HIV infection. This strategy also involves regular visits with a service provider to test for HIV and other sexually transmitted infections (STIs), monitor side effects and receive adherence and risk-reduction support. Several randomized, placebo-controll...

Journal: :مجله علوم اعصاب شفای خاتم 0
mokhtar ahmadi islamic azad university, mashhad branch, mashhad, iran pouya ghaderi islamic azad university, mashhad branch, mashhad, iran fatemeh shahbeigi islamic azad university, mashhad branch, mashhad, iran reza hosseini islamic azad university, mashhad branch, mashhad, iran

curcumin is a hydrophobic polyphenol and major bioactive component of turmeric with known anti-inflammatory, neurogenesis, antioxidant, and anti-carcinogenic effect. curcumin antagonizes many steps in the inflammatory cascade, including inhibition of nf-κb (nuclear factor kappa-light-chain-enhancer of activated b cells), activator protein-1 transcription and inos (induced nitric oxide synthases...

2018

Background Tuberculous meningitis (TBM) is the most severe form of tuberculosis. Co-infection with HIV increases the risk of developing TBM, complicates treatment, and substantially worsens outcome. Whether corticosteroids confer a survival benefit in HIV-infected patients with TBM remains uncertain. Hepatitis is the most common drug-induced serious adverse event associated with anti-tuberculos...

2017
Paula Ordonez Simone Kunzelmann Harriet C. T. Groom Melvyn W. Yap Simon Weising Chris Meier Kate N. Bishop Ian A. Taylor Jonathan P. Stoye

SAMHD1 is an intracellular enzyme that specifically degrades deoxynucleoside triphosphates into component nucleoside and inorganic triphosphate. In myeloid-derived dendritic cells and macrophages as well as resting T-cells, SAMHD1 blocks HIV-1 infection through this dNTP triphosphohydrolase activity by reducing the cellular dNTP pool to a level that cannot support productive reverse transcripti...

Journal: :African journal of AIDS research : AJAR 2012
Nicole Mamotte

Injecting drug use is a growing problem in Africa and a growing risk factor for contracting HIV in the region. It is imperative that HIV research includes injecting drug users so that they too are able to benefit from safe and effective behavioural interventions and biomedical HIV prevention and treatment products. This article relates a critical review of the findings of a desk review of previ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2003
F Li R Goila-Gaur K Salzwedel N R Kilgore M Reddick C Matallana A Castillo D Zoumplis D E Martin J M Orenstein G P Allaway E O Freed C T Wild

New HIV therapies are urgently needed to address the growing problem of drug resistance. In this article, we characterize the anti-HIV drug candidate 3-O-(3',3'-dimethylsuccinyl) betulinic acid (PA-457). We show that PA-457 potently inhibits replication of both WT and drug-resistant HIV-1 isolates and demonstrate that the compound acts by disrupting a late step in Gag processing involving conve...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید